Psoriasis is a common debilitating disease for which there are many treatment options, creating complex choices for patients and clinicians. Patient decision aids (PDAs), decision-supporting tools that facilitate shared decision-making, may engender a collaborative process between physician and patient. The design of PDAs typically focuses on conveying information about evidence-based treatment options and the value-sensitive nature of the decisions.1,2 To help patients better align treatment choices with their personal values, the specifics of patient treatment preferences must be more elaborately embedded into the design of PDAs.3,4 We undertook detailed assessment of treatment decision-making experiences of patients with psoriasis to discover key patient preferences that can be incorporated into a subsequent PDA design for these patients.
Kim J, Kim DJ, Ortenzio FS, Dare L, Frank C, Kost RG, Lowes MA. Patients With Psoriasis and Personalized Trade-offs in Treatment Decisions—Lessons Learned From Focus Groups. JAMA Dermatol. 2016;152(6):720-722. doi:10.1001/jamadermatol.2016.0501